General Information of the Compound
Compound ID
CP0382738
Compound Name
BIIB-074
    Show/Hide
Synonyms
(5R)-5-(4-[2-
B5927
BC600719
BIIB074
CNV1014082
HY-12796
    Show/Hide
Structure
Formula
C18H19FN2O2
Molecular Weight
314.36
Canonical SMILES
NC(=O)[C@@H]1CC[C@@H](N1)c1ccc(OCc2ccccc2F)cc1
    Show/Hide
InChI
InChI=1S/C18H19FN2O2/c19-15-4-2-1-3-13(15)11-23-14-7-5-12(6-8-14)16-9-10-17(21-16)18(20)22/h1-8,16-17,21H,9-11H2,(H2,20,22)/t16-,17+/m1/s1
    Show/Hide
InChIKey
JESCETIFNOFKEU-SJORKVTESA-N
CAS
934240-30-9
Physicochemical Property
logP
2.6831
Rotatable Bonds
5
Heavy Atom Count
23
Polar Areas
64.35
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
3
Complexity
23

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 16046068
ChEMBL ID
CHEMBL3544913
DrugBank ID
DB11706
Clinical Information about the Compound
Drug 1 ( BIIB074 )
Drug Name BIIB074
Company Biogen
Indication
Bipolar disorder
Phase 2
Lumbosacral radiculopathy
Phase 2
Trigeminal neuralgia
Phase 2
Target(s)
Voltage-gated sodium channel alpha Nav1.7 (SCN9A)
Inhibitor